Tenet Healthcare (THC)
(Delayed Data from NYSE)
$165.21 USD
-3.31 (-1.96%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $165.15 -0.06 (-0.04%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$165.21 USD
-3.31 (-1.96%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $165.15 -0.06 (-0.04%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth C Momentum A VGM
Zacks News
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Here's How Much a $1000 Investment in Tenet Healthcare Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
HCA Healthcare Stock Up 12.7% in 6 Months: What Should Investors Do?
by Zubia Masood
HCA is expected to benefit from growing volumes and operational efficiency. However, declining outpatient surgeries and the impact of hurricanes might partially offset the positives.
Pediatrix Medical Stock Soars 30.5% Since Q3 Earnings Beat
by Zacks Equity Research
MD expects transformational and restructuring-related expenses to be $48 million in 2024.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Tenet (THC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Tenet Stock Jumps 19.6% Since Q3 Results: What Should Investors Do?
by Kaibalya Pravo Dey
THC continues to experience strong demand for its services, which is expected to continue throughout the year.
Tenet Healthcare and Starbucks have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Tenet Healthcare and Starbucks are part of the Zacks Bull and Bear of the Day article.
Bull of the Day: Tenet Healthcare (THC)
by Derek Lewis
Tenet Healthcare shares have been scorching-hot in 2024, up 115% and outperforming many of the Mag 7 members.
Teladoc Health Q3 Loss Narrows on Strong Integrated Care Unit
by Zacks Equity Research
TDOC expects 2024 U.S. Integrated Care Members to remain within 93.5-94.5 million.
The Zacks Analyst Blog Highlights XLV, Tenet Healthcare, PKB and Dycom Industries
by Zacks Equity Research
XLV, Tenet Healthcare, PKB and Dycom Industries are part of the Zacks top Analyst Blog.
Tenet (THC) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Analyzing Universal Health's Q3 Earnings: To Buy or Keep Your Cool?
by Debasmita Chatterjee
UHS is well-poised to benefit from growing patient volumes and extensive treatment network, partly offset by elevated operating costs.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
2 Sector ETFs & Stocks Likely to Benefit Despite Soft October Jobs Data
by Sanghamitra Saha
The U.S. economy added 12,000 jobs in October, down sharply from September and below the Dow Jones estimate for 100,000.
Tenet Q3 Earnings Beat on Strong Ambulatory Unit, '24 EPS View Raised
by Zacks Equity Research
THC's Q3 results benefit from higher same-hospital admissions and Medicaid supplemental revenue gains. Cost-cutting measures help offset challenges from hospital divestitures.
Play Likely Earnings Beat With 4 Top-Ranked Stocks
by Sanghamitra Saha
Top-ranked stocks Tenet Healthcare (THC), Fortinet (FTNT), Leidos (LDOS) and American Airlines (AAL) are likely to beat on the bottom line in their upcoming releases.
New Strong Buy Stocks for November 1st
by Zacks Equity Research
SKY, AAT, SOHO, THC and LDOS have been added to the Zacks Rank #1 (Strong Buy) List on November 1, 2024.
Zacks Investment Ideas feature highlights: Pfizer, Philip Morris and Tenet Healthcare
by Zacks Equity Research
Pfizer, Philip Morris and Tenet Healthcare are part of the Zacks Investment Ideas article.
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should You Buy, Hold or Sell HCA Healthcare Stock After Q3 Earnings?
by Zubia Masood
HCA is poised to benefit from volume growth and expansion initiatives.
Humana Q3 Earnings Beat on Growing Premiums & Cost Management
by Zacks Equity Research
Better-than-expected Medicare Advantage membership aids HUM's third-quarter results.
3 Stocks to Buy Following Robust Quarterly Results
by Derek Lewis
Throughout the Q3 reporting cycle, several companies, including Pfizer, Philip Morris, and Tenet Healthcare, have stolen the spotlight, with each raising guidance.
Stock Market News for Oct 30, 2024
by Zacks Equity Research
Wall Street ended mixed on Tuesday as U.S. job openings dropped to their lowest level in over three years.